Mon, Jan 26, 2015, 12:57 AM EST - U.S. Markets open in 8 hrs 33 mins

Recent

% | $
Quotes you view appear here for quick access.

Lpath Inc. Message Board

  • john_j_315 john_j_315 Jun 19, 2014 1:35 PM Flag

    How it's done:

    " OPKO Health, Inc. (OPK), a multinational biopharmaceutical and diagnostics company that is developing a novel long-acting human growth hormone product (hGH-CTP) for the treatment of growth hormone deficiency (GHD), today announced it will hold a conference call and webcast on Tuesday, June 24, 2014 at 8:30 a.m. EDT (7:30 a.m. CDT).

    During the call, OPKO Biologics management will discuss data from the company's advanced phase 2 trial of hGH-CTP in growth hormone deficient pediatric subjects. The pharmacokinetic and pharmacodynamics portion of the results will also be presented at a poster presentation on the prior Monday afternoon from 2:00 p.m. to 4:00 p.m. EDT (1:00 p.m. to 3:00 p.m. CDT) during the International Congress of Endocrinology and Endocrine Society's Annual Meeting and Expo at the McCormick Place West in Chicago, IL."

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
LPTN
2.96-0.01(-0.34%)Jan 23 3:55 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.